Graybug Vision Makes Key Hires to Further Build Momentum Beh

BALTIMORE, Jan. 20, 2022 -- Graybug Vision, Inc. , a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic... | January 20, 2022

Related Keywords

Johns Hopkins University , Maryland , United States , Arizona , Fang Li , Anhui , China , Redwood City , California , Xiamen , Fujian , Wuhan , Hubei , Nanjing , Jiangsu , Baltimore , Ali Kakavand , Fred Guerard , Head Of Program Management , Program Management , Arizona State University , Regulatory Affairs , Neurosciences Institute , Johns Hopkins University School Of Medicine , Nasdaq , Exchange Commission , Graybug Research Development , Wuhan University , Graybug Vision Inc , China Pharmaceutical University , Astrazeneca , Xiamen University , Regulatory Affairs At Hurley Consulting Associated Ltd , Vice President , Hurley Consulting Associated , Portfolio Management , Biomedical Engineering , Nasdaq Listing Rule , Johns Hopkins University School , Private Securities Litigation Reform Act , Graybug Vision , Nc Stock Exchange , News , Information , Press Release , 022 , Raybug , Iopharmaceutical , Company , Ocused , N , Developing , Ransformative , Medicines , Or , The , Treatment , F , Diseases , Retina , Nd Gray Us38942q1031 ,